New study pits popular Weight-Loss drug against strict diet for diabetes control
NCT ID NCT07272343
Summary
This study is comparing two approaches for people newly diagnosed with type 2 diabetes who also have excess liver fat. For 12 weeks, one group will receive weekly injections of the medication semaglutide, while the other will follow a strict calorie-restricted diet. Researchers want to see which method is better at controlling blood sugar, promoting weight loss, and reducing liver fat.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Minde road No.1
RECRUITINGJiangxi, Nanchang, 330000, China
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.